Annual Total Assets
$354.78 M
-$136.08 M-27.72%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual total assets is $354.78 million, with the most recent change of -$136.08 million (-27.72%) on December 31, 2023.
- During the last 3 years, ADCT annual total assets has fallen by -$158.91 million (-30.93%).
- ADCT annual total assets is now -42.59% below its all-time high of $617.97 million, reached on December 31, 2021.
Performance
ADCT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$349.08 M
-$22.70 M-6.11%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly total assets is $349.08 million, with the most recent change of -$22.70 million (-6.11%) on September 30, 2024.
- Over the past year, ADCT quarterly total assets has dropped by -$5.70 million (-1.61%).
- ADCT quarterly total assets is now -45.28% below its all-time high of $637.98 million, reached on September 30, 2021.
Performance
ADCT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ADCT Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.7% | -1.6% |
| 3 y3 years | -30.9% | -43.5% |
| 5 y5 years | +135.6% | -43.5% |
ADCT Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.6% | at low | -43.5% | +13.3% |
| 5 y | 5-year | -42.6% | +157.7% | -45.3% | +153.5% |
| alltime | all time | -42.6% | +157.7% | -45.3% | +153.5% |
ADC Therapeutics SA Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $349.08 M(-6.1%) |
| Jun 2024 | - | $371.78 M(+20.7%) |
| Mar 2024 | - | $307.97 M(-13.2%) |
| Dec 2023 | $354.78 M(-27.7%) | $354.78 M(-24.0%) |
| Sep 2023 | - | $466.90 M(-8.0%) |
| Jun 2023 | - | $507.30 M(+8.5%) |
| Mar 2023 | - | $467.67 M(-4.7%) |
| Dec 2022 | $490.86 M(-20.6%) | $490.86 M(-7.7%) |
| Sep 2022 | - | $531.76 M(+2.2%) |
| Jun 2022 | - | $520.46 M(-10.6%) |
| Mar 2022 | - | $581.89 M(-5.8%) |
| Dec 2021 | $617.97 M | $617.97 M(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $637.98 M(+37.4%) |
| Jun 2021 | - | $464.39 M(+0.6%) |
| Mar 2021 | - | $461.70 M(-10.1%) |
| Dec 2020 | $513.69 M(+273.1%) | $513.69 M(-1.5%) |
| Sep 2020 | - | $521.53 M(+39.5%) |
| Jun 2020 | - | $373.84 M(+171.5%) |
| Dec 2019 | $137.68 M(-8.6%) | - |
| Dec 2019 | - | $137.68 M(-31.4%) |
| Jun 2019 | - | $200.84 M(+33.4%) |
| Dec 2018 | $150.56 M(-44.6%) | - |
| Dec 2018 | - | $150.56 M |
| Dec 2017 | $271.95 M(+75.4%) | - |
| Dec 2016 | $155.08 M | - |
FAQ
- What is ADC Therapeutics SA annual total assets?
- What is the all time high annual total assets for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual total assets year-on-year change?
- What is ADC Therapeutics SA quarterly total assets?
- What is the all time high quarterly total assets for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly total assets year-on-year change?
What is ADC Therapeutics SA annual total assets?
The current annual total assets of ADCT is $354.78 M
What is the all time high annual total assets for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual total assets is $617.97 M
What is ADC Therapeutics SA annual total assets year-on-year change?
Over the past year, ADCT annual total assets has changed by -$136.08 M (-27.72%)
What is ADC Therapeutics SA quarterly total assets?
The current quarterly total assets of ADCT is $349.08 M
What is the all time high quarterly total assets for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly total assets is $637.98 M
What is ADC Therapeutics SA quarterly total assets year-on-year change?
Over the past year, ADCT quarterly total assets has changed by -$5.70 M (-1.61%)